Contributed article
SAFFORD — Cordis and Mt. Graham Regional Medical Center announced MGRMC’s Cardiac Cath Lab is the first in Arizona, as well as the Southwest, to utilize the newly FDA-approved SELUTION SLR drug-eluting balloon from Cordis.
It is the only FDA-approved sirolimus drug-eluting balloon in the United States for the treatment of coronary in-stent restenosis. The technology delivers medication directly to the artery while leaving no additional permanent implant behind.
In a press release, MGRMC officials said, “We are incredibly proud of Michael Jerman, M.D. and the Cath Lab team for continuing to expand the treatment options available to patients in southeastern Arizona.”




